Test Price
2,800 AEDโ Home Collection Available
GFI1B Gene Platelet-Type Bleeding Disorder 17 (Genetic Test) in UAE | 2800 AED | DNA Labs UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The GFI1B gene test uses Next Generation Sequencing to identify mutations associated with platelet-type bleeding disorder 17, a hereditary macrothrombocytopenia causing mild to moderate bleeding tendency. This definitive molecular diagnosis enables precise clinical management and informed family screening. The assay targets all coding exons and flanking intronic regions of the GFI1B gene, delivering variant detection with 99.9% sensitivity for single nucleotide variants and small indels.
| Feature | Our NGS Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Sensitivity | 99.9% for coding variants | Limited, misses deep intronic/novel changes |
| Methodology | NGS (Next Generation Sequencing) | Sanger (exon-by-exon) |
| Turnaround Time | 3โ4 Weeks | 4โ6 Weeks |
Physician Insight & Safety Protocols
"This genetic test provides a definitive molecular diagnosis for platelet-type bleeding disorder 17, enabling precise clinical management and informed family screening. Results must always be correlated with the patient's full hematological profile and interpreted within the context of their bleeding history and family pedigree." โ Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Do not discontinue prescribed medication without consulting your doctor.
Platelet function and bleeding risk assessments require a stable clinical baseline. Abruptly stopping antiplatelet or anticoagulant therapy prior to testing may lead to thrombotic complications. Always consult your haematologist before any medication changes.
Exclusion Criteria
- Active Infection or Acute Illness: Febrile states or systemic infections may transiently alter platelet counts and function, confounding test interpretation. Defer testing until clinically stable.
- Recent Major Surgery or Trauma: Surgical stress and transfusions can mask hereditary platelet defects. Allow a minimum of 4 weeks recovery before sampling.
- Emergency Red Flags: Sudden severe headache, vision changes, uncontrolled mucosal bleeding, or signs of intracranial haemorrhage require immediate emergency care (call 998).
Patient FAQ & Clinical Guidance
1. What does the GFI1B gene test diagnose?
The GFI1B gene test definitively identifies inherited mutations causing platelet-type bleeding disorder 17, confirming macrothrombocytopenia and guiding targeted management. This molecular diagnosis clarifies the bleeding risk profile and enables cascade screening for at-risk family members.
2. How is the sample collected and when will I receive results?
A simple blood draw or buccal swab is collected by our DHA-licensed phlebotomist at your home via temperature-controlled cold-chain logistics. Results are delivered within 3โ4 weeks from sample receipt at the laboratory.
3. Does insurance cover this genetic test in the UAE?
Many UAE insurance plans cover genetic testing for hereditary bleeding disorders when deemed medically necessary. Our team verifies your coverage directly via WhatsApp +971 54 548 8731 and assists with pre-authorisation documentation.
4. Who should consider this test?
Individuals with a personal or family history of unexplained bruising, epistaxis, menorrhagia, prolonged bleeding after surgery or dental extractions, and those with suspected inherited thrombocytopenia may benefit from GFI1B genetic testing.
UAE Regulatory & Data Privacy Adherence
DHA Licensed Facility No. 1143 ยท Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE
All data handling complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability. ISO 9001:2015 Certified (INT/EGQ/2509DA/3139).
Clinical & Logistical Metadata
| Test Name | GFI1B Gene Platelet-Type Bleeding Disorder 17 (Genetic Test) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3โ4 Weeks |
| Sample Type / Matrix | Peripheral Whole Blood (EDTA) or Buccal Swab |
| Methodology Used | Next Generation Sequencing (NGS) |
| ICD-10-CM Code | D69.1 |
| LOINC Code | 82327-2 |
| DHA Facility License & Laboratory Address | License No. 1143 ยท Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE ยท DNA Labs UAE |
ุฏุนู ุซูุงุฆู ุงููุบุฉ ู ุชุงุญ
ุงูุชุญูู ู ู ุงูุชุบุทูุฉ ุงูุชุฃู ูููุฉ
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
ุชููู ุนู ุงูุชุฎู ูู. ุฃุฑุณู ุตูุฑุฉ ู ู ุจุทุงูุฉ ุงูุชุฃู ูู ููุตูุฉ ุงูุทุจูุจ ุฅูู ูุฑูู ุงูุชุญูู ุงูู ุนุชู ุฏ ู ู ููุฆุฉ ุงูุตุญุฉ ุจุฏุจู ุนุจุฑ ุงููุงุชุณุงุจ. ุงุญุตู ุนูู ุชุญุฏูุซ ุงูุญุงูุฉ ูู ุฏูุงุฆู.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians